Home > Publications database > Occurrence of high-grade glioma in Noonan syndrome: Report of two cases. > print

001     143310
005     20240229112547.0
024 7 _ |a 10.1002/pbc.27625
|2 doi
024 7 _ |a pmid:30693642
|2 pmid
024 7 _ |a 0098-1532
|2 ISSN
024 7 _ |a 1096-911X
|2 ISSN
024 7 _ |a 1545-5009
|2 ISSN
024 7 _ |a 1545-5017
|2 ISSN
037 _ _ |a DKFZ-2019-00900
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a El-Ayadi, Moatasem
|0 0000-0001-9791-0104
|b 0
245 _ _ |a Occurrence of high-grade glioma in Noonan syndrome: Report of two cases.
260 _ _ |a New York, NY
|c 2019
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1573808289_8873
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Noonan syndrome (NS) is an autosomal dominant disorder commonly caused by PTPN11 germline mutations. Patients are characterized by short stature, congenital heart defects, facial dysmorphism, and increased risk of malignancies including brain tumors. Commonly associated brain tumors are dysembryoplastic neuroepithelial tumor and low-grade glioma. We report two cases of anaplastic astrocytoma with PTPN11-related NS. We conducted a systematic search of medical databases looking for other reported cases of high-grade glioma associated with NS and identified 24 cases of brain tumors, all of which were low-grade glial or glioneuronal tumors except for one case of medulloblastoma.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Ansari, Marc
|b 1
700 1 _ |a Kühnöl, Caspar D
|b 2
700 1 _ |a Bendel, Anne
|0 0000-0002-2062-0974
|b 3
700 1 _ |a Sturm, Dominik
|0 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
|b 4
|u dkfz
700 1 _ |a Pietsch, Torsten
|b 5
700 1 _ |a Kramm, Christof M
|b 6
700 1 _ |a von Bueren, André O
|0 0000-0003-4197-6264
|b 7
773 _ _ |a 10.1002/pbc.27625
|g Vol. 66, no. 5, p. e27625 -
|0 PERI:(DE-600)2130978-4
|n 5
|p e27625
|t Pediatric blood & cancer
|v 66
|y 2019
|x 1545-5017
909 C O |p VDB
|o oai:inrepo02.dkfz.de:143310
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PEDIATR BLOOD CANCER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21